PLX PHARMA INC. — Form D

PLX PHARMA INC. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2013-07-08. The offering totals $9.0M, of which $9.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2013-07-08
• Form: D
• Accession: 0001291520-13-000003
• Industry: Pharmaceuticals
• Exemptions: 06
• Total offering: $9.0M
• Amount sold: $9.0M
• Minimum investment: $25K
• Investors: 51
• Date of first sale: 2013-05-28
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-199168

Issuer

• Name: PLX PHARMA INC.
• CIK: 0001291520
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 8285 EL RIO STREET, HOUSTON, TX, 77054
• Phone: 713-842-1249

Officers, directors & promoters (26)

Showing 25 of 26 people.

Other filings by this issuer (5)

More

• CIK 1291520 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search